BRCA1 and Lynch syndrome: Although tools have been developed for all three Tier 1 conditions, there are a larger number of tools, at more advanced stages of development and implementation for BRCA1/2 testing, compared to FH and Lynch syndrome (Manchanda et al., 2016; Bangash et al., 2022; Pande et al., 2022).